Indaptus Therapeutics Inc. Common Stock (INDP)
Stock · NASDAQ · Health Care
$2.65as of 10/16/2026
Price chart
Active signals
INDP Signal Track Record
How signals performed across all stocks →What INDP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 27 | +2.9% | 52% | July 27, 2026 |
| Bollinger Band Breakout | 17 | -10.9% | 35% | September 8, 2026 |
| Volume Spike | 14 | +12.8% | 79% | September 2, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -0.2% | 50% | October 7, 2026 |
| Any 20-session window (baseline) | -7.3% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About INDP
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- indaptusrx.com/
Fundamentals
- 1-day range
- $2.25$2.89
- Market cap
- $166.55M
- P/E (trailing)
- —
- P/E (forward)
- -2.05
- EPS (trailing)
- $-7.75
- Dividend yield
- —
- Beta
- 0.99
- Avg. volume
- 867.9K
- Dividend pay date
- October 30, 2020
Indaptus Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- INDPIndaptus Therapeutics Inc. Common Stock$2.63▼ 7.72%Market cap $166.55MP/E —$0.92$5.96
- PEPGPepGen Inc. Common Stock$2.6▲ 2.77%Market cap $166.70MP/E —$1.31$7.8
- OKUROnKure Therapeutics Inc. Class A Common Stock$2.1▼ 1.41%Market cap $168.06MP/E —$2.13$5.38
- NKTXNkarta Inc. Common Stock$1.8▼ 6.74%Market cap $163.84MP/E —$1.7$3.72
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$10.34▼ 8.25%Market cap $172.81MP/E —$5.5$24.17
- AARDAardvark Therapeutics Inc. Common Stock$3.78▼ 2.07%Market cap $159.75MP/E —$3.35$16.6
- KRROKorro Bio Inc. Common Stock$8.49▼ 8.81%Market cap $174.80MP/E —$5.2$55.89
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| INDP Indaptus Therapeutics Inc. Common Stock | $166.55M | — | $2.63 | ▼ 7.72% | $0.92$5.96 |
| PEPG PepGen Inc. Common Stock | $166.70M | — | $2.6 | ▲ 2.77% | $1.31$7.8 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $168.06M | — | $2.1 | ▼ 1.41% | $2.13$5.38 |
| NKTX Nkarta Inc. Common Stock | $163.84M | — | $1.8 | ▼ 6.74% | $1.7$3.72 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $10.34 | ▼ 8.25% | $5.5$24.17 |
| AARD Aardvark Therapeutics Inc. Common Stock | $159.75M | — | $3.78 | ▼ 2.07% | $3.35$16.6 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $8.49 | ▼ 8.81% | $5.2$55.89 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Which stocks are gapping on Wednesday?ChartMill · 9/30/2026
- MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even BetterYahoo · 9/25/2026
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · 9/15/2026
- Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On TuesdayBenzinga · 9/15/2026
- Crude Oil Down 3%; Kroger Shares Gain After Upbeat Q2 EarningsBenzinga · 9/11/2026
- Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On FridayBenzinga · 9/11/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 70.6K
- Total value held
- $128.5K
- Institutional holders
- 6
- Unknown39.0K
- Unknown27.0K
- Unknown2.7K
- Unknown1.9K
- Unknown17
- Unknown2
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Indaptus named among top small-cap healthcare performers
Indaptus Therapeutics was highlighted in a recent report as one of five smaller health care stocks that outperformed Moderna in September. The stock is currently trading near the upper end of its 52-week range, reflecting this recent strength. This inclusion in a performance-based list draws attention to the company's recent market activity relative to larger peers.
Indaptus named among top small-cap healthcare performers. Indaptus Therapeutics was highlighted in a recent report as one of five smaller health care stocks that outperformed Moderna in September. The stock is currently trading near the upper end of its 52-week range, reflecting this recent strength. This inclusion in a performance-based list draws attention to the company's recent market activity relative to larger peers.